Table 3 Side effects and complications after PLB
Complications | Pethidine group (n = 48) | Placebo group (n = 50) | |
|---|---|---|---|
Nausea | 0 | 0 | NS (p = 1) |
Vomiting | 0 | 0 | NS (p = 1) |
Vasovagal reaction | 5 (10%) | 4 (8%) | NS (p = 0.74) |
Serious complications | 0 | 0 | NS (p = 1) |
Complications | Pethidine group (n = 48) | Placebo group (n = 50) | |
|---|---|---|---|
Nausea | 0 | 0 | NS (p = 1) |
Vomiting | 0 | 0 | NS (p = 1) |
Vasovagal reaction | 5 (10%) | 4 (8%) | NS (p = 0.74) |
Serious complications | 0 | 0 | NS (p = 1) |